Fathom Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Fathom Therapeutics - overview
Established
2023
Location
New York, NY, US
Primary Industry
Biotechnology
About
Fathom Therapeutics founded in 2023 in New York, US, specializes in computational drug discovery by leveraging physics-based simulations, AI, and advanced molecular design. Its atomic precision platform models biomolecular motion and predicts protein-ligand interactions, helping pharmaceutical and biotech companies accelerate drug development for complex targets like protein-protein interfaces and targeted protein degraders.
Current Investors
Alexandria Venture Investments, Sutter Hill Ventures, New York Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Healthcare IT, Molecular Chemicals, Medicinal Chemicals & Botanicals
Website
www.fathomtx.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.